← Back to Search

N/A

Counterpressure Maneuvers for Fainting (DETECT-ED Trial)

N/A
Recruiting
Led By Shubhayan Sanatani, MD
Research Sponsored by Dr. Victoria Claydon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Those between the ages of 6-18 years (inclusive)
Be younger than 65 years old
Must not have
Epilepsy recurrence
Known history of traumatic head injury
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
No Placebo-Only Group

Summary

This trial will assess whether counterpressure maneuvers (CPM) can prevent syncope in children. In stage I, participants will fill out a survey about their syncopal episode and any prodromal symptoms. In stage II, some participants will be trained in CPM and all will be followed for one year. Surveys and medical records will be used to assess syncopal and presyncopal recurrence and changes in medical diagnosis.

Who is the study for?
This trial is for kids aged 6-18 who've fainted recently and show up at the emergency room between 10 am and 10 pm. They should be able to understand English to fill out surveys. Kids with heart rhythm problems, head injuries, seizures, drug overdoses, or certain fainting conditions without warning signs can't join.
What is being tested?
The study tests if special body-tightening exercises (like crossing legs) help stop fainting in kids when added to normal care they get in the ER. Half will just get regular care; the other half will learn these exercises too. Everyone's followed for a year with monthly check-ins on their fainting spells.
What are the potential side effects?
There are no direct side effects from learning counterpressure maneuvers since they're simple physical actions like leg crossing or arm tensing. Usual care in the ER doesn't change except for adding these exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 6 and 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My epilepsy has come back.
Select...
I have had a traumatic head injury in the past.
Select...
I have a known history of heart disease.
Select...
I have a known heart rhythm problem.
Select...
I have recently started having seizures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Syncope
Secondary study objectives
Documentation of typical prodromal symptoms
Number of patients with exercise-related syncope
Number of patients with syncope secondary to other causes
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Counterpressure ManeuversExperimental Treatment1 Intervention
Participants will receive standard of care treatment (behavioural intervention and avoidance measures, as indicated in "Usual Care"), alongside training in counter pressure maneuvers. Training in counterpressure maneuvers will be delivered through a handout and video that will show three maneuvers (i.e. arm-tensing, squatting, and leg-crossing) that patients enrolled in the intervention arm can perform when they begin to experience common signs and symptoms of syncope. Patients will be instructed to start with one of the maneuvers and if their symptoms do not go away, move on to a second or third maneuver if needed.
Group II: Usual CareActive Control1 Intervention
Participants will receive standard of care treatment for their diagnosis of syncope. This primarily includes behavioural interventions and avoidance measures (e.g., stay hydrated, increase salt intake, avoid hot situations, avoid standing for long periods of time, engage in regular physical activity). Some patients may be prescribed medication (Midodrine, Fludrocortisone) at the discretion of their physician.

Find a Location

Who is running the clinical trial?

University of British ColumbiaOTHER
1,466 Previous Clinical Trials
2,485,156 Total Patients Enrolled
3 Trials studying Orthostatic Intolerance
103 Patients Enrolled for Orthostatic Intolerance
Dr. Victoria ClaydonLead Sponsor
Simon Fraser UniversityOTHER
57 Previous Clinical Trials
10,388 Total Patients Enrolled
1 Trials studying Orthostatic Intolerance
30 Patients Enrolled for Orthostatic Intolerance

Media Library

Counterpressure Maneuvers (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT05555771 — N/A
Orthostatic Intolerance Research Study Groups: Usual Care, Counterpressure Maneuvers
Orthostatic Intolerance Clinical Trial 2023: Counterpressure Maneuvers Highlights & Side Effects. Trial Name: NCT05555771 — N/A
Counterpressure Maneuvers (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05555771 — N/A
~95 spots leftby Nov 2025